News AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:03 2025-12-05 am EST			5-day change	1st Jan Change
13,592.00 ^GBX	+0.58%		-2.73%	+29.84%

Dec. 05	European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	MT
Dec. 05	Swedish stocks in North America - Ericsson fell 1.0 percent	FW

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	Dec. 05	MT
Swedish stocks in North America - Ericsson fell 1.0 percent	Dec. 05	FW
Salesforce?S Agentforce Life Sciences Selected by Astrazeneca as Its Unified Global Platform to Help Transform Customer Engagement	Dec. 04	CI
ASTRAZENECA : Bernstein remains its Buy rating	Dec. 04	ZD
Owkin Announces International Validation Results of BRCAura: AI-Driven Screening for gBRCA Mutations Directly From Pathology Slides	Dec. 04	AQ
AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH	Dec. 04	RE
Neurimmune expands collaboration with AstraZeneca to develop and commercialize Fibril Depleter NI009 for AL Amyloidosis	Dec. 04	RE
Neurimmune Expands Collaboration with Alexion to Develop and Commercialize Fibril Depleter NI009 for AL Amyloidosis	Dec. 04	CI
AstraZeneca PLC Advances Hematology and Cell Therapy Ambition with Largest-Ever Presence at ASH	Dec. 04	CI
AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASH	Dec. 04	BU
UK stocks rise on boost from industrials and financials	Dec. 04	RE
UK's FTSE 100 ends lower as financials stocks drag	Dec. 03	RE
Global markets live: Amazon, Nvidia, UPS, Airbus, Volvo…	Dec. 03
AstraZeneca Remains Top Pick at Morgan Stanley - BN	Dec. 03	FW
Swedish stocks in North America - Astra Zeneca fell 1.1 percent	Dec. 03	FW
UK Government to Consult Executives from AstraZeneca, GSK on New Drug Pricing Regime	Dec. 03	MT
Sector Update: Health Care Stocks Lower Tuesday Afternoon	Dec. 02	MT
European Equities Close Mixed in Tuesday Trading; Euro Area Inflation Rises 2.2% in November	Dec. 02	MT
UK's FTSE 100 Flat; Major Lenders Pass Central Bank Stress Test	Dec. 02	MT
AstraZeneca, GSK to Join UK Working Group on New Drug-Pricing Framework	Dec. 02	MT
AstraZeneca's New Drug Application Accepted Under FDA Priority Review in the US for Patients with Hard-To-Control Hypertension	Dec. 02	CI
Baxdrostat new drug application accepted under FDA priority review in the US for patients with hard-to-control hypertension	Dec. 02	RE
Zero-tariff deal with US to cost NHS GBP1 billion, No 10 says	Dec. 02	AN
Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension	Dec. 02	BU
AstraZeneca gets closer to US approval for hypertension drug	Dec. 02	AN

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

AstraZeneca benefits from oncology momentum but valuation limits upside

November 19, 2025 at 07:43 am EST

AstraZeneca Profit Beats Estimates on Cancer, Diabetes Drugs

November 06, 2025 at 12:55 pm EST

AstraZeneca's CEO reportedly considers listing in the United States

July 02, 2025 at 03:39 am EDT